First time evaluation of myocardium microRNA profile in Anderson-Fabry disease: implications in the pathological processes

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Costantina Catalano

S. Orsola-Malpighi Policlinic, Bologna (Italy)

6 More presentations in this session

Presentation thumbnail

MicroRNA-145-5p restricts cardiac scar resolution during cardiac regeneration

Doctor H. Wang (Helsinki, FI)

Abstract Slides Video

Presentation thumbnail

Direct in vivo cardiac reprogramming with circular RNA of single transcription factor delivered by fibroblast-targeting lipid nanoparticles

Mr Q. Wang (Shanghai, CN)

Abstract Slides

Presentation thumbnail

The implantation of a left ventricular assist device causes changes in the aortic miRNome and proteome - an integrative analysis

Miss S. Chytilova (Praggue, CZ)

Abstract Slides

Presentation thumbnail

Inhibition of microRNA-181c-5p rescues diabetes-impaired angiogenesis through activation of key mediators of angiogenesis, cell survival and novel genes, elmo3 and trib1

Doctor E. Solly (Adelaide, AU)

Abstract Slides

Presentation thumbnail

Investigating N6-methyladenosin RNA modification as a mediator of microRNA mechanical regulation in the heart

Professor C. Emanueli (London, GB)

Abstract Slides

Access the full session

Session thumbnail

Non-coding RNA control of cardiovascular diseases

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

T2 mapping as a marker of active myocardial injury in Anderson-Fabry disease patients

Congress Presentation

Cardiovascular prognostic determinants in anderson-fabry disease: insights from a multicenter cohort study

Congress Presentation

Cardiac magnetic resonance findings in Fabry disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources